Table 1.

Patient characteristics

Characteristic	Number of patients (%)
Performance status
0	74 (84.1)
1	12 (13.6)
2	2 (2.3)
Gender
Male	67 (76.1)
Female	21 (23.9)
Stage
II B	22 (25.0)
T1N1M0: 11, T2aN1M0: 5,
T2bN1M0: 6
III	36 (40.9)
T1N2M0: 13, T2bN2M0: 9,
T3N0M0: 3 T3N1M0: 2, T3N2M0: 9
IV A	16 (18.2)
T4N0M0: 3, T4N1M0: 3, T4N2M0: 10
IV B	13 (14.8)
T1N3M0: 6, T2aN3M0: 1, T2bN3M0:
1 T3N3M0: 2, T4N3M0: 3
IV C	1 (1.1)
T3N2M1: 1
Histology
WHO type I	18 (20.5)
WHO type II	32 (36.4)
WHO type III	38 (43.2)